Injectable Artesunate Toolkit - Videos New video - Artesunate injection for severe malaria: New formulation based on arginine (Argesun® 60 mg)
27 Sep 2024 Risk factors for death among children with severe malaria, Ivukula sub-county, Namutumba district, Eastern Uganda, September 2021– February 2022
06 Sep 2024 Perceived barriers and opportunities for the introduction of post-discharge malaria chemoprevention (PDMC) in five sub-Saharan countries: a qualitative survey amongst malaria key stakeholders
21 Aug 2024 Improving adherence to severe malaria treatment guidelines in children at a Ugandan regional hospital: assessment of a quality improvement initiative
WHO prequalifies diagnostic test to support safer administration of P. vivax malaria treatments On 18 December 2024, the (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) infection. The prequalification of this test was followed by the prequalification of two new tafenoquine products for anti-relapse treatment of P. vivax malaria in December. 08 Jan 2025
Reinvigorated global efforts needed to curb rising malaria threat New data from the World Health Organization (WHO) reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated 263 million cases and 597 000 malaria deaths worldwide in 2023. This represents about 11 million more cases in 2023 compared to 2022, and nearly the same number of deaths. Approximately 95% of the deaths occurred in the WHO African Region, where many at risk still lack access to the services they need to prevent, detect and treat the disease. 11 Dec 2024
12 Feb 2025 9th International Conference on Plasmodium vivax Research (ICPvR) 2025 The 9th International Conference on Plasmodium vivax Research (ICPvR 2025). This esteemed gathering will convene leading experts globally to discuss the latest advancements in P. vivax research, address critical knowledge gaps, and promote collaborative efforts towards its elimination. Puducherry, India
17 Feb 2025 African Union summit 2025 The summit will bring together member states, philanthropic funders, representatives from various Ministries in Africa and civil society to recommit for the Africa we want ahead of Agenda 2063. More details will be shared in due course; stay tuned!! Addis Ababa, Ethiopia
03 Dec 2024 Treatment outcomes and associated factors in severe malaria patients at University of Gondar Hospital, Northwest Ethiopia: A retrospective study (2020-2023) Treatment outcomes associated factors on severe malaria among patients in North West of Ethiopia.
27 Nov 2024 Prevalence and factors associated with placental malaria in Lira District, Northern Uganda: a cross-sectional study Malaria has a stable perennial transmission across Uganda. Placental malaria is associated with adverse maternal, fetal, and neonatal outcomes. The aim of the study was to assess the prevalence of placental malaria and to determine its associated factors among parturient women in Lira District, Uganda.
09 Nov 2024 Cost of treating severe malaria in children in Africa: a systematic literature review Malaria is a major cause of ill health and death in children in Africa. The disease also imposes a severe social and economic burden on households and health systems and is strongly associated with poverty. This study summarizes the most up-to-date cost of treating severe malaria in children in Africa.
07 Oct 2024 Quality of care and post-discharge morbidity among children diagnosed with severe malaria in rural Uganda: A prospective cohort study Kniss JM, Kibaba G, Baguma E, Bhattarai Chhetri S, Hendren C, Ntaro M, et al.